INVO Bioscience Launches INVOcell Procedure in South America in Newly Created INVO Centers and Existing In Vitro Fertilization (IVF) Centers

BEVERLY, Mass.--(BUSINESS WIRE)--INVO Bioscience, Inc. (OTC BB: IVOB), a medical device company focused on treatment options for patients diagnosed with infertility, announced today that the first South American INVO Center has officially opened in Cali, Colombia, and six existing In-Vitro Fertilization (IVF) centers located in Armenia, Cúcuta, Bogotá, Ibagué, Medellin and Ubate, Colombia are also now offering the INVO procedure. INVO Bioscience’s patented product, the INVOcell, allows for vaginal incubation of eggs, sperm and early embryo development during the infertility treatment process.

MORE ON THIS TOPIC